Schonfeld Strategic Advisors LLC Biotechnology

Schonfeld Strategic Advisors LLC

$15 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
SAGE Sage Therapeutics, Inc.	$521M	$318,000 0.0% of portfolio	40,000	Q1 2025 New
ETON Eton Pharmaceuticals, Inc.	$380M	$314,000 0.0% of portfolio	24,213	Q1 2025 Reduced 73.0%
ABEO Abeona Therapeutics Inc.	$38.4M	$309,000 0.0% of portfolio	65,011	Q1 2025 Added 6.11%
NTLA Intellia Therapeutics, Inc.	$971M	$295,000 0.0% of portfolio	41,590	Q1 2025 Reduced 71.42%
MRUS Merus N.V.	$3.01B	$295,000 0.0% of portfolio	7,031	Q1 2025 Added 30.2%
ARQT Arcutis Biotherapeutics, Inc.	$904M	$288,000 0.0% of portfolio	18,466	Q1 2025 Reduced 19.71%
HALO Halozyme Therapeutics, Inc.	$8.19B	$287,000 0.0% of portfolio	4,511	Q1 2025 New
RVPH Reviva Pharmaceuticals Holdings, Inc.	$8.18M	$245,000 0.0% of portfolio	258,197	Q1 2025 Reduced 75.6%
GOSS Gossamer Bio, Inc.	$167M	$221,000 0.0% of portfolio	201,715	Q1 2025 Added 30.39%
ANNX Annexon, Inc.	$121M	$214,000 0.0% of portfolio	111,201	Q1 2025 Added 135.1%
GMAB Genmab A/S	$15.6B	$207,000 0.0% of portfolio	10,589	Q1 2025 New
LIFE A Tyr Pharma Inc	$53.2M	$191,000 0.0% of portfolio	102,706	Q1 2025 Added 61.4%
KROS Keros Therapeutics, Inc.	$370M	$158,000 0.0% of portfolio	15,558	Q1 2025 New
MDXG Mimedx Group, Inc.	$778M	$141,000 0.0% of portfolio	18,600	Q1 2025 New
SEER Seer, Inc.	$128M	$140,000 0.0% of portfolio	83,377	Q1 2025 Added 87.42%
CRVS Corvus Pharmaceuticals, Inc.	$214M	$126,000 0.0% of portfolio	39,783	Q1 2025 Reduced 69.18%
THRD Third Harmonic Bio, Inc.	$219M	$104,000 0.0% of portfolio	30,106	Q1 2025 Reduced 90.66%
XFOR X4 Pharmaceuticals, Inc	$122M	$80,000 0.0% of portfolio	335,436	Q1 2025 Reduced 75.92%
RCKT Rocket Pharmaceuticals, Inc.	$243M	$76,000 0.0% of portfolio	11,432	Q1 2025 New
OLMA Olema Pharmaceuticals, Inc.	$187M	$75,000 0.0% of portfolio	20,020	Q1 2025 Reduced 96.04%
ELEV Elevation Oncology, Inc.	$8.85M	$71,000 0.0% of portfolio	275,390	Q1 2025 Reduced 17.37%
AIKI A Ikido Pharma Inc.	$20.8M	$67,000 0.0% of portfolio	17,700	Q1 2025 New
DMAC Dia Medica Therapeutics Inc.	$130M	$62,000 0.0% of portfolio	16,483	Q1 2025 Reduced 36.84%
COGT Cogent Biosciences, Inc.	$802M	$60,000 0.0% of portfolio	10,080	Q1 2025 Added 0.8%
ENTA Enanta Pharmaceuticals Inc	$152M	$59,000 0.0% of portfolio	10,800	Q1 2025 New
MNOV Medicinova Inc	$66.2M	$51,000 0.0% of portfolio	35,138	Q1 2025 Reduced 1.71%
IMUX Immunic, Inc.	$32.4M	$49,000 0.0% of portfolio	45,774	Q1 2025 New
EPIX Essa Pharma Inc.	$82.9M	$36,000 0.0% of portfolio	22,843	Q1 2025 Reduced 53.23%
MCRB Seres Therapeutics, Inc.	$1.66B	$35,000 0.0% of portfolio	51,300	Q1 2025 Reduced 49.06%
PMCB Pharma Cyte Biotech, Inc.	$20.1M	$31,000 0.0% of portfolio	25,500	Q1 2025 Reduced 0.78%
STTK Shattuck Labs, Inc.	$36.9M	$29,000 0.0% of portfolio	30,700	Q1 2025 Reduced 17.91%
ANTX An2 Therapeutics, Inc.	$21.5M	$27,000 0.0% of portfolio	20,115	Q1 2025 Reduced 25.22%
PMVP Pmv Pharmaceuticals, Inc.	$65.7M	$24,000 0.0% of portfolio	22,900	Q1 2025 Reduced 34.94%
SGMO Sangamo Therapeutics, Inc	$93.9M	$20,000 0.0% of portfolio	31,425	Q1 2025 Reduced 98.16%
SLS Sellas Life Sciences Group, Inc.	$37M	$13,000 0.0% of portfolio	12,481	Q1 2025 New
CORT Corcept Therapeutics Inc	$7.24B	$11,000 0.0% of portfolio	100	Q1 2025 New
NXTC Next Cure, Inc.	$163M	$9,000 0.0% of portfolio	18,935	Q1 2025 Reduced 13.14%
VOR Vor Biopharma Inc.	$81.8M	$9,000 0.0% of portfolio	13,425	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.